BRUSSELS, April 9 (Reuters) - Pharmaceutical group Fagron said sales growth in the first quarter slowed slightly from the second half of last year, but maintained its full-year outlook.
The company, which makes ingredients for pharmacists to make bespoke medicines, said sales in the first quarter increased by 29.8 percent from last year to 117.8 million euros ($126.92 million).
Also read: Brewers sign Eric Thames to 3-year deal
16:37 Wu-Tang Clan U-God Sues RZA and the Whole Clan For $2.5 MILLION!12
13:37 GoPro to cut about 15 percent of workforce13
14:49 Trump warns of ‘retribution’ for companies that offshore jobs, threatening 35 percent tariff7
18:05 DP World, Quebec's Caisse to create C$5 billion investment vehicle12